News tagged with b cell
New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
Cancer
May 01, 2013 |
not rated yet |
0
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
4.5 / 5 (2) |
0
Novel therapeutic approaches to cure chronic HBV infection
Exciting new data presented today at the International Liver Congress 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for ...
Diseases, Conditions, Syndromes
Apr 25, 2013 |
not rated yet |
0
Video reveals cancer cells' Achilles' heel (w/ Video)
(Medical Xpress)—Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could ...
Cancer
Apr 24, 2013 |
5 / 5 (2) |
0
|
Scientists find ethnicity linked to antibodies
(Medical Xpress)—Cracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity research.
Genetics
Apr 17, 2013 |
5 / 5 (2) |
0
|
Molecule treats leukemia by preventing cancer cell repair, scientists report
(Medical Xpress)—Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment ...
Cancer
Apr 17, 2013 |
4.7 / 5 (3) |
0
|
Study finds interferon, one of the body's proteins, induces persistent viral infection
Scientists at The Scripps Research Institute (TSRI) have made a counterintuitive finding that may lead to new ways to clear persistent infection that is the hallmark of such diseases as AIDS, hepatitis B and hepatitis C.
Medical research
Apr 11, 2013 |
5 / 5 (3) |
0
|
New genetic screen paves the way for long-sought treatments for liver disease
Chronic liver failure is a major health problem that causes about one million deaths around the world each year. A study published April 11th by Cell Press in the journal Cell reveals a new type of screen for identifying genes ...
Medical research
Apr 11, 2013 |
not rated yet |
0
New cutting-edge cell research will lead to safer medical experiments on humans
In almost 90 per cent of cases, novel drugs tested on humans by pharmaceutical companies do not work as intended and must be scrapped. Often the drugs do not work, while at worst, test subjects die. New research from the ...
Medical research
Apr 10, 2013 |
5 / 5 (1) |
0
Immunotherapy showed promising antileukemia activity in pediatric patients
Researchers using patients' own immune cells in an immunotherapy approach called "anti-CD19 chimeric antigen receptor (CAR) T-cell therapy," achieved responses in children whose acute lymphocytic leukemia (ALL) had returned ...
Cancer
Apr 07, 2013 |
5 / 5 (1) |
0
Nothing fishy about it: Fish oil can boost the immune system
Fish oil rich in DHA and EPA is widely believed to help prevent disease by reducing inflammation, but until now, scientists were not entirely sure about its immune enhancing effects. A new report appearing in the April 2013 ...
Immunology
Apr 01, 2013 |
5 / 5 (2) |
0
New vaccine-design approach targets HIV and other fast-mutating viruses
A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against ...
HIV & AIDS
Mar 28, 2013 |
4.8 / 5 (6) |
1
|
Monoclonal antibody targets, kills leukemia cells
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
Cancer
Mar 25, 2013 |
5 / 5 (4) |
0
|
Ultrasound to combat liver tumours
Liver tumours are either benign or malignant; if malignant then they can be primary or secondary. In Europe, a solitary lesion in the liver is more likely to be a metastatic carcinoma than a primary liver ...
Cancer
Mar 25, 2013 |
not rated yet |
0
